Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 135	$ 22	$ 206	$ 37
Cost of sales	271	9	546	20
Gross (Loss) Profit	(136)	13	(340)	17
Operating Expenses
Research and development	657	237	1,219	324
Sales and marketing	1,943	913	2,219	917
General and administrative	2,720	476	3,757	578
Total Operating Expenses	5,320	1,626	7,195	1,819
Loss from Operations	(5,456)	(1,613)	(7,535)	(1,802)
Other Income (Expense)
Gain on investments	35	0	36	0
Interest expense	(88)	(62)	(362)	(73)
Other income (expense)	21	0	20	(1)
Total Other Expense	(32)	(62)	(306)	(74)
Net Loss	(5,488)	(1,675)	(7,841)	(1,876)
Loss attributable to non-controlling interest		(10)	0	(11)
Net Loss Attributable to Tenon Medical, Inc.	$ (5,488)	$ (1,665)	$ (7,841)	$ (1,865)
Net Loss Attributable to Tenon Medical, Inc. Per Share of Common Stock
Basic	$ (0.65)	$ (2.01)	$ (1.66)	$ (2.21)
Diluted	$ (0.65)	$ (2.01)	$ (1.66)	$ (2.21)
Weighted-Average Shares of Common Stock Outstanding
Basic	8,422	830	4,726	842
Diluted	8,422	830	4,726	842
Statement of Comprehensive Income [Abstract]
Net loss	$ (5,488)	$ (1,675)	$ (7,841)	$ (1,876)
Unrealized loss on investments	(27)	0	(27)	0
Foreign currency translation adjustment	(21)	0	(21)	0
Total Comprehensive Loss	(5,536)	(1,675)	(7,889)	(1,876)
Comprehensive loss attributable to non-controlling interest	0	(10)	0	(11)
Total comprehensive loss attributable to Tenon Medical, Inc.	$ (5,536)	$ (1,665)	$ (7,889)	$ (1,865)